Covid-19
Conditions
Keywords
Covid-19, antiviral mask, nano ivermectin
Brief summary
Antiviral efficacy of Ivermectin against Covid-19 in vitro was stated by many stusies all over the world with decreased effecacy in vivo so ,usage of masks impregnated into nano Ivermectin solution will theoretically increase the protective action of the ordinary masks
Detailed description
Antiviral effecacy of Ivermectin against Covid-19 in vitro was stated by many stusies all over the world with decreased effecacy in vivo so ,usage of masks impregnated into nano Ivermectin solution will theoretically increase the protective action of the ordinary masks this study is a trial for evaluation of adding a proved antiviral material to the mask and to compare between the protective value of this mask and the ordinary one.
Interventions
OTHERivermectin impregnated mask
mask with ivermectin nano solution
Sponsors
South Valley University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Intervention model description
Sequential Assignment
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* health care personells and family contact of confirmed COVID-19 cases.
Exclusion criteria
* refusal of participate to use the masks. * pregnancy or lactation known hypersensitivity to ivermectin.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of persons in each group who Complain of any suspected Symptoms | within 14 days after enrollement | ( Fever, Myalgia ,Cough, Sore Throat, Diarrhea, Shortness of Breath) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of persons in each group who are diagnosed as COVID-19 patients | within 21 days after enrollement | swab test |
Countries
Egypt
Contacts
Primary ContactZaky Aref
Backup Contactmohammed hosny hassaan
Outcome results
None listed